Human leucocyte interferon-alpha therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-alfa 2a

Eur J Cancer. 1994;30A(11):1729-30. doi: 10.1016/0959-8049(94)90604-1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibody Formation
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / immunology
  • Interferon-alpha / therapeutic use*
  • Middle Aged
  • Polycythemia Vera / therapy*
  • Recombinant Proteins
  • Thrombocythemia, Essential / therapy*

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins